Cargando…

Could Temperamental Features Modulate Participation in Clinical Trials?

The prodromal stages of Alzheimer’s disease (AD) are the primary focus of research aimed at slowing disease progression. This study explores the influence of affective temperament on the motivation of people with mild cognitive impairment (MCI) and subjective cognitive decline (SCD) to participate i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cintoli, Simona, Elefante, Camilla, Radicchi, Claudia, Brancati, Giulio Emilio, Bacciardi, Silvia, Bonaccorsi, Joyce, Siciliano, Gabriele, Maremmani, Icro, Perugi, Giulio, Tognoni, Gloria
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9917573/ https://www.ncbi.nlm.nih.gov/pubmed/36769768 http://dx.doi.org/10.3390/jcm12031121

Ejemplares similares

Psychiatric Symptoms in Patients with Cerebral Endometriosis: A Case Report and Literature Review
por: Elefante, Camilla, et al.
Publicado: (2022)

Prevalence and Clinical Correlates of Comorbid Anxiety and Panic Disorders in Patients with Parkinson’s Disease
por: Elefante, Camilla, et al.
Publicado: (2021)

Confabulations in Cases of Dementia: Atypical Early Sign of Alzheimer’s Disease or Misleading Feature in Dementia Diagnosis?
por: Belli, Elisabetta, et al.
Publicado: (2020)

Mild Behavioral Impairment in Psychogeriatric Patients: Clinical Features and Psychopathology Severity
por: Elefante, Camilla, et al.
Publicado: (2023)

The long-term outcome of patients with heroin use disorder/dual disorder (chronic psychosis) after admission to enhanced methadone maintenance
por: Maremmani, Angelo G. I., et al.
Publicado: (2018)

Correlations Between Awareness of Illness (Insight) and History of Addiction in Heroin-Addicted Patients
por: Maremmani, Angelo Giovanni Icro, et al.
Publicado: (2012)

Challenges of Treating ADHD with Comorbid Substance Use Disorder: Considerations for the Clinician
por: Barbuti, Margherita, et al.
Publicado: (2023)

Further Evidence of a Specific Psychopathology of Addiction. Differentiation from Other Psychiatric Psychopathological Dimensions (Such as Obesity)
por: Maremmani, Angelo G.I., et al.
Publicado: (2017)

Symptomatological Variants and Related Clinical Features in Adult Attention Deficit Hyperactive Disorder
por: Pallucchini, Alessandro, et al.
Publicado: (2021)

Anti-AMPA-Receptor Encephalitis Presenting as a Rapid-Cycling Bipolar Disorder in a Young Woman with Turner Syndrome
por: Quaranta, Giuseppe, et al.
Publicado: (2015)

Mild Cognitive Impairment in de novo Parkinson's Disease: Selective Attention Deficit as Early Sign of Neurocognitive Decay
por: Cammisuli, Davide Maria, et al.
Publicado: (2021)

Substance Use Disorder in Adult-Attention Deficit Hyperactive Disorder Patients: Patterns of Use and Related Clinical Features
por: Spera, Vincenza, et al.
Publicado: (2020)

Remarkable Reduction of Cocaine Use in Dual Disorder (Adult Attention Deficit Hyperactive Disorder/Cocaine Use Disorder) Patients Treated with Medications for ADHD
por: Manni, Corrado, et al.
Publicado: (2019)

Influence of Substance Use Disorder on Treatment Retention of Adult-Attention-Deficit/Hyperactive Disorder Patients. A 5-Year Follow-Up Study
por: Pallucchini, Alessandro, et al.
Publicado: (2021)

Adult-Attention Deficit Hyperactive Disorder Symptoms Seem Not to Influence the Outcome of an Enhanced Agonist Opioid Treatment: A 30-Year Follow-Up
por: Maremmani, Angelo G. I., et al.
Publicado: (2021)

Psychopathology of addiction: Can the SCL90-based five-dimensional structure differentiate Heroin Use Disorder from a non-substance-related addictive disorder such as Gambling Disorder?
por: Maremmani, Angelo G. I., et al.
Publicado: (2018)

Does Cannabis, Cocaine and Alcohol Use Impact Differently on Adult Attention Deficit/Hyperactivity Disorder Clinical Picture?
por: Spera, Vincenza, et al.
Publicado: (2021)

Symptomatological Features of Patients with and without Ecstasy Use during Their First Psychotic Episode
por: Rugani, Fabio, et al.
Publicado: (2012)

The mental status of 1090 heroin addicts at entry into treatment: should depression be considered a 'dual diagnosis'?
por: Maremmani, Icro, et al.
Publicado: (2007)

Exploring the Role of Caffeine Use in Adult-ADHD Symptom Severity of US Army Soldiers
por: Cipollone, Giada, et al.
Publicado: (2020)

Psychiatric Aspects of Obesity: A Narrative Review of Pathophysiology and Psychopathology
por: Weiss, Francesco, et al.
Publicado: (2020)

Clonazepam as Agonist Substitution Treatment for Benzodiazepine Dependence: A Case Report
por: Maremmani, Angelo Giovanni Icro, et al.
Publicado: (2013)

Toward the Identification of a Specific Psychopathology of Substance Use Disorders
por: Maremmani, Angelo G. I., et al.
Publicado: (2017)

Substance Use/Dependence in Psychiatric Emergency Setting Leading to Hospitalization: Predictors of Continuity of Care
por: Maremmani, Angelo Giovanni Icro, et al.
Publicado: (2022)

Six-Month Outcome in Bipolar Spectrum Alcoholics Treated with Acamprosate after Detoxification: A Retrospective Study
por: Maremmani, Angelo Giovanni Icro, et al.
Publicado: (2014)

Subtyping patients with heroin addiction at treatment entry: factor derived from the Self-Report Symptom Inventory (SCL-90)
por: Maremmani, Icro, et al.
Publicado: (2010)

Clinical presentations of substance abuse in bipolar heroin addicts at time of treatment entry
por: Maremmani, Icro, et al.
Publicado: (2012)

Erratum to: Agonist Opioid Treatment as historical comprehensive treatment (‘Dole & Nyswander’ methodology) is associated with better toxicology outcome than Harm Reduction Treatment
por: Bizzarri, Jacopo V., et al.
Publicado: (2017)

The newer Opioid Agonist Treatment with lower substitutive opiate doses is associated with better toxicology outcome than the older Harm Reduction Treatment
por: Bizzarri, Jacopo V., et al.
Publicado: (2016)

Comparison of Emotional Dysregulation Features in Cyclothymia and Adult ADHD
por: Brancati, Giulio Emilio, et al.
Publicado: (2021)

Characteristics of Stress Sensitivity in Heroin Use Disorder Patients during Their Opioid Agonist Treatment
por: Della Rocca, Filippo, et al.
Publicado: (2023)

The Temperamental Factor in Disease
Publicado: (1908)

Comorbidities in Youth with Bipolar Disorder: Clinical Features and Pharmacological Management
por: Sesso, Gianluca, et al.
Publicado: (2023)

Prevalence and psychiatric comorbidities of night-eating behavior in obese bariatric patients: preliminary evidence for a connection between night-eating and bipolar spectrum disorders
por: Brancati, Giulio Emilio, et al.
Publicado: (2021)

Temperamental Selection of Institutional Patients
Publicado: (1920)

History of Childhood/Adolescence Referral to Speciality Care or Treatment in Adult Patients with Attention-Deficit/Hyperactivity Disorder: Mutual Relations with Clinical Presentation, Psychiatric Comorbidity and Emotional Dysregulation
por: Brancati, Giulio Emilio, et al.
Publicado: (2023)

Prevalence and diagnostic distribution of medically unexplained painful somatic symptoms across 571 major depressed outpatients
por: Fornaro, Michele, et al.
Publicado: (2011)

Mitochondrial ANT-1 related adPEO leading to cognitive impairment: is there a link?
por: Simoncini, Costanza, et al.
Publicado: (2017)

The impact of Mild Behavioral Impairment on the individual’s level of psychological, social, and occupational functioning
por: Elefante, C., et al.
Publicado: (2022)

Does heroin addiction makes temperamental changes?
por: Martinova, Hristina, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_j7k4u1196nngmp3tkp4u334mhg